Skip to main content
. 2021 Nov 11;18(4):2484–2503. doi: 10.1007/s13311-021-01151-1

Fig. 6.

Fig. 6

Systemic administration of the AAV-hE2F4DN vector prevents memory deficits and clasping behavior in h5xFAD mice. (a) Percentage of alternation in the Y-maze test of 3-month-old h5xFAD transgenic mice subjected to systemic administration of the AAV-EGFP control vector or the AAV-hE2F4DN vector. (F(3,45) = 3.75619, p = 0.017; one-way ANOVA; WT/EGFP vs h5xFAD/EGFP: q = 13.742, p = 0.036; h5xFAD/EGFP vs h5xFAD/hE2F4DN: q = 10.204, p = 0.043; Tukey’s HSD post hoc test). (b) Number of arms entered in the Y-maze test of 3-month-old h5xFAD transgenic mice subjected to systemic administration of the AAV-EGFP control vector or the AAV-hE2F4DN vector. (F(3,45) = 0.20931, p = 0.889; one-way ANOVA). (c) Analysis of paw-clasping behavior in h5xFAD mice of 9 months, either noninjected (N-I) or injected with AAV-EGFP (EGFP) or AAV-hE2F4DN (hE2F4DN). (h5xFAD/EGFP vs h5xFAD/hE2F4DN: K(9) = 4.267, p = 0.039; Kruskal–Wallis test). (d) hE2F4DN expression prevents spatial memory impairment in homozygous 5xFAD mice as evaluated by the MWM test at 6 months of age. Latency time to reach the hidden platform along four training days in homozygous 5xFAD mice either noninjected or injected with the AAV-hE2F4DN vector and in noninjected wild-type mice (left). Statistical significant differences between WT and h5xFAD mice, but not between WT and h5xFAD mice administered with AAV-E2F4DN, were observed at training day 4 (F(2,15) = 4.0569, p = 0.039; one-way ANOVA; h5xFAD vs WT: q = 16.4475, p = 0.037; Tukey’s HSD post hoc test]. No statistically significant differences among experimental groups were observed for velocity of swimming (one-way ANOVA) (right). *p < 0.05 (Tukey’s HSD post hoc test)